CCDC64-GALNT9 Fusion FISH Probe
The CCDC64-GALNT9 Fusion FISH Probe is used to confirm a fusion of the CCDC64 and GALNT9 genes. The fusion of the CCDC64 and GALNT9 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CCDC64-GALNT9-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CCDC64-GALNT9-20-AQAQ | 20 (40 μL) | 200 μL |
|
GALNT9 Gene Summary
This gene encodes a member of the UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes. GalNAc-Ts initiate mucin-type O-linked glycosylation in the Golgi apparatus by catalyzing the transfer of GalNAc to serine and threonine residues on target proteins. They are characterized by an N-terminal transmembrane domain, a stem region, a lumenal catalytic domain containing a GT1 motif and Gal/GalNAc transferase motif, and a C-terminal ricin/lectin-like domain. GalNAc-Ts have different, but overlapping, substrate specificities and patterns of expression. This gene is expressed specifically in the brain, with highest expression in the cerebellum. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Gene Name: Polypeptide N-acetylgalactosaminyltransferase 9
Chromosome: CHR12: 132680916 -132905905
Locus: 12q24.33
Gene Diseases
The CCDC64 GALNT9 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|